282 related articles for article (PubMed ID: 33567947)
1. Ibrutinib-induced acute kidney injury via interstitial nephritis.
Markóth C; File I; Szász R; Bidiga L; Balla J; Mátyus J
Ren Fail; 2021 Dec; 43(1):335-339. PubMed ID: 33567947
[TBL] [Abstract][Full Text] [Related]
2. A case report of pre-eclampsia-like endothelial injury in the kidney of an 85-year-old man treated with ibrutinib.
Li A; Ambruso SL; Oto OA; Barry M; Edelstein CL
BMC Nephrol; 2022 Jul; 23(1):264. PubMed ID: 35870899
[TBL] [Abstract][Full Text] [Related]
3. Bruton's tyrosine kinase inhibitors and the kidney: Focus on ibrutinib.
Brener ZZ; Brener H; Losev A
J Oncol Pharm Pract; 2020 Oct; 26(7):1735-1737. PubMed ID: 32054411
[TBL] [Abstract][Full Text] [Related]
4. Azithromycin-Induced, Biopsy-Proven Acute Interstitial Nephritis in an Adult Successfully Treated with Low-Dose Corticosteroids.
Woodruff AE; Meaney CJ; Hansen EA; Prescott GM
Pharmacotherapy; 2015 Nov; 35(11):e169-74. PubMed ID: 26598102
[TBL] [Abstract][Full Text] [Related]
5. Acute tubulointerstitial nephritis and IgM deposits on glomerular capillary walls after immunotherapy with nivolumab for metastatic renal cell carcinoma.
Irifuku T; Satoh A; Tani H; Mandai K; Masaki T
CEN Case Rep; 2020 Feb; 9(1):48-54. PubMed ID: 31605271
[TBL] [Abstract][Full Text] [Related]
6. Acute granulomatous interstitial nephritis secondary to bisphosphonate alendronate sodium.
Peña de la Vega L; Fervenza FC; Lager D; Habermann T; Leung N
Ren Fail; 2005; 27(4):485-9. PubMed ID: 16060139
[TBL] [Abstract][Full Text] [Related]
7. Acute interstitial nephritis of HIV-positive patients under atazanavir and tenofovir therapy in a retrospective analysis of kidney biopsies.
Schmid S; Opravil M; Moddel M; Huber M; Pfammatter R; Keusch G; Ambuhl P; Wuthrich RP; Moch H; Varga Z
Virchows Arch; 2007 Jun; 450(6):665-70. PubMed ID: 17464512
[TBL] [Abstract][Full Text] [Related]
8. Ibrutinib treatment via alternative administration in a patient with chronic lymphocytic leukemia and dysphagia.
DiSogra KY; Tran T; Arnall JR; Janes A; Moore DC; Park SI
J Oncol Pharm Pract; 2021 Jul; 27(5):1265-1269. PubMed ID: 33106104
[TBL] [Abstract][Full Text] [Related]
9. Megalocytic interstitial nephritis following acute pyelonephritis with Escherichia coli bacteremia: a case report.
Kwon HJ; Yoo KH; Kim IY; Lee S; Jang HR; Kwon GY
J Korean Med Sci; 2015 Jan; 30(1):110-4. PubMed ID: 25552891
[TBL] [Abstract][Full Text] [Related]
10. Real-world ibrutinib dose reductions, holds and discontinuations in chronic lymphocytic leukemia.
Hou JZ; Ryan K; Du S; Fang B; Marks S; Page R; Peng E; Szymanski K; Winters S; Le H
Future Oncol; 2021 Dec; 17(35):4959-4969. PubMed ID: 34783255
[TBL] [Abstract][Full Text] [Related]
11. Truth or dare: switching BRAF/MEK inhibitors after acute interstitial nephritis in a patient with metastatic melanoma - A case report and review of the literature.
De Ryck L; Delanghe S; Jacobs C; Fadaei S; Brochez L; Saerens M
Acta Clin Belg; 2023 Jun; 78(3):215-222. PubMed ID: 35996969
[TBL] [Abstract][Full Text] [Related]
12. Acute granulomatous interstitial nephritis in a patient with metastatic melanoma on targeted therapy with dabrafenib and trametinib-A case report.
Krelle A; Mathai VK; Kirkland G; Nott L; Jose MD; Whale K
Cancer Rep (Hoboken); 2022 Jul; 5(7):e1520. PubMed ID: 34350734
[TBL] [Abstract][Full Text] [Related]
13. Ibrutinib in Advanced Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Lower Risk of Hepatitis B Virus Reactivation.
Yang S; Zhu R; Li N; Feng Y; Zuo R; Gale RP; Huang X
Acta Haematol; 2022; 145(1):54-62. PubMed ID: 34569486
[TBL] [Abstract][Full Text] [Related]
14. Ibrutinib does not prevent kidney fibrosis following acute and chronic injury.
Belliere J; Casemayou A; Colliou E; El Hachem H; Kounde C; Piedrafita A; Feuillet G; Schanstra JP; Faguer S
Sci Rep; 2021 Jun; 11(1):11985. PubMed ID: 34099830
[TBL] [Abstract][Full Text] [Related]
15. [Clinical and pathological analysis of IgA nephropathy with acute kidney injury].
Chen MG; Ye XH; Liang HY; Yang Q
Zhonghua Er Ke Za Zhi; 2016 Aug; 54(8):610-3. PubMed ID: 27510875
[TBL] [Abstract][Full Text] [Related]
16. Drug-induced acute interstitial nephritis: pathology, pathogenesis, and treatment.
Krishnan N; Perazella MA
Iran J Kidney Dis; 2015 Jan; 9(1):3-13. PubMed ID: 25599729
[TBL] [Abstract][Full Text] [Related]
17. Bruton's Tyrosine Kinase Inhibitors Impair FcγRIIA-Driven Platelet Responses to Bacteria in Chronic Lymphocytic Leukemia.
Naylor-Adamson L; Chacko AR; Booth Z; Caserta S; Jarvis J; Khan S; Hart SP; Rivero F; Allsup DJ; Arman M
Front Immunol; 2021; 12():766272. PubMed ID: 34912339
[TBL] [Abstract][Full Text] [Related]
18. [Acute interstitial nephritis: clinical presentation and diagnosis].
Dos Reis D; Moll S; De Seigneux S; Berchtold L
Rev Med Suisse; 2022 Mar; 18(771):364-369. PubMed ID: 35235259
[TBL] [Abstract][Full Text] [Related]
19. Facing the Challenge of Drug-Induced Acute Interstitial Nephritis.
Sanchez-Alamo B; Cases-Corona C; Fernandez-Juarez G
Nephron; 2023; 147(2):78-90. PubMed ID: 35830831
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoids Induce Partial Remission of Focal Segmental Glomerulosclerosis but Not Interstitial Nephritis in COVID-19 Acute Kidney Injury in an APOL1 Low-Risk Genotype White Patient.
Nowak PJ; Forycka J; Cegielska N; Harendarz K; Wągrowska-Danilewicz M; Danilewicz M; Płoszaj T; Borowiec M; Wlazeł R; Nowicki M
Am J Case Rep; 2021 Nov; 22():e933462. PubMed ID: 34727096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
